NDRG1 protein overexpression in malignant thyroid neoplasms

Clinics

Volumn 65, Issue 8, 2010, Pages 757-762

  Gerhard, Renê ^a   Nonogaki, Suely ^b   Fregnani, José Humberto Tavares Guerreiro ^c   Soares, Fernando Augusto ^d   Nagai, Maria Aparecida ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO ADOLFO LUTZ   (Brazil)

^c BARRETOS CANCER HOSPITAL   (Brazil)

^d A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

Immunohistochemistry; NDRG1; Thyroid carcinoma; Thyroid gland; Tissue microarray

Indexed keywords

CELL CYCLE PROTEIN; N MYC DOWNSTREAM REGULATED GENE 1 PROTEIN; N-MYC DOWNSTREAM-REGULATED GENE 1 PROTEIN; PARAFFIN; SIGNAL PEPTIDE; TUMOR PROTEIN;

ADENOMA; ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; METABOLISM; MICROARRAY ANALYSIS; MIDDLE AGED; PATHOLOGY; THYROID TUMOR;

ADENOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL CYCLE PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHATIC METASTASIS; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; NEOPLASM PROTEINS; PARAFFIN EMBEDDING; THYROID NEOPLASMS; YOUNG ADULT;

EID: 77957694283     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322010000800004     Document Type: Article

References (35)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71-96, doi: 10.3322/CA.2007.0010.
2. Mirra AP, Latorre MRDO, Veneziano DB. Incidência de câncer no município de São Paulo, Brasil, 1997-2003. In: Incidência de câncer no município de São Paulo, Brasil, 1997-2003; Tendência no período 1969- 2003; Mortalidade por câncer no município de São Paulo, Brasil, 1997- 2003. In: Mirra AP, Latorre MRDO, Veneziano DB, editors. Registro de Câncer de São Paulo. 2007. pp 9-21.
3. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295:2164-7, doi: 10.1001/jama.295. 18.2164.
4. Kent WD, Hall SF, Isolato PA, Houlden RL, George RL, Groome PA. Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease. CMAJ. 2007;177:1357-61.
5. DeLellis RA, Williams ED. Thyroid and parathyroid tumors: introduction. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C, editors. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs. Lyon: IARC Press; 2004. pp 51-6.
6. Hirokawa M, Carney JA, Goellner JR, DeLellis RA, Heffess CS, Katoh R, et al. Observer variation of encapsulated follicular lesions of the thyroid gland. Am J Surg Pathol. 2002;26:1508-14, doi: 10.1097/00000478-200211000-00014.
7. Franc B, de la Salmonière P, Lange F, Hoang C, Louvel A, de Roquancourt A, et al. Interobserver and intraobserver reproducibility in the histopathology of follicular thyroid carcinoma. Hum Pathol. 2003;34:1092-100, doi: 10.1016/S0046-8177(03)00403-9.
8. Lloyd RV, Erickson LA, Casey MB, Lam KY, Lohse CM, Asa SL, et al. Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol. 2004;28:1336-40, doi: 10.1097/01. pas.0000135519.34847.f6.
9. Asa SL. The role of immunohistochemical markers in the diagnosis of follicular-patterned lesions of the thyroid. Endocr Pathol. 2005;16:295-309, doi: 10.1385/EP:16:4:295.
10. Kokame K, Kato H, Miyata T. Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis. J Biol Chem. 1996;271:29659-65, doi: 10.1074/jbc.271.47.29659.
11. Kalaydjieva L, Hallmayer J, Chandler D, Savov A, Nikolova A, Angelicheva D, et al. Gene mapping in Gypsies identifies a novel demyelinating neuropathy on chromosome 8q24. Nat Genet. 1996;14:214-17, doi: 10.1038/ng1096-214.
12. Lachat P, Shaw P, Gebhard S, van Belzen N, Chaubert P, Bosman FT. Expression of NDRG1, a differentiation-related gene, in human tissues. Histochem Cell Biol. 2002;118:399-408, doi: 10.1007/s00418-002-0460-9.
13. Qu X, Zhai Y, Wei H, Zhang C, Xing G, Yu Y, et al. Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family. Mol Cell Biochem. 2002;229:35-44, doi: 10. 1023/A:1017934810825.
14. Shimono A, Okuda T, Kondoh H. N-myc-dependent repression of ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-myc mutant. Mech Dev. 1999;83:39-52, doi: 10. 1016/S0925-4773(99)00025-8.
15. Piquemal D, Joulia D, Balaguer P, Basset A, Marti J, Commes T. Differential expression of the RTP/Drg/Ndr1 gene product in proliferating and growth arrested cells. Biochim Biophys Acta. 1999;1450:364-73, doi: 10.1016/S0167-4889(99)00056-7.
16. Ellen TP, Ke Q, Zhang P, Costa M. NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states. Carcinogenesis. 2008;29:2-8, doi: 10.1093/carcin/bgm200.
17. Salnikow K, An WG, Melillo G, Blagosklonny MK, Costa M. Nickelinduced transformation shifts the balance between HIF-1 and p53 transcription factors. Carcinogenesis. 1999;20:1819-23, doi: 10.1093/ carcin/20.9.1819.
18. Cangul H. Hypoxia upregulates the expression of the NDRG1 gene leading to its overexpression in various human cancers. BMC Genet. 2004;5:27, doi: 10.1186/1471-2156-5-27.
19. Stein S, Thomas EK, Herzog B, Westfall MD, Rocheleau V, Jackson II RS, et al. NDRG1 is necessary for p53-dependent apoptosis. J Biol Chem. 2004;279:48930-40, doi: 10.1074/jbc.M400386200.
20. Guan RJ, Ford HL, Fu Y, Li Y, Shaw LM, Pardee AB. DRG-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res. 2000;60:749-55.
21. Bandyopadhyay S, Pai SK, Gross SC, Hirota S, Hosobe S, Miura K, et al. The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Res. 2003;63:1731-6.
22. Chua M-S, Sun H, Cheung ST, Mason V, Higgins J, Ross DT, et al. Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma. Mod Pathol. 2007;20:76-83, doi: 10.1038/ modpathol.3800711.
23. Nishio S, Ushijima K, Tsuda N, Takemoto S, Kawano K, Yamaguchi T, et al. Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma. Cancer Lett. 2008; 264:36-43, doi: 10.1016/j.canlet.2008.01.020.
24. Sobin LH, Wittekind Ch. TNM classification of malignant tumours. John Wiley & Sons, Inc: New York; 2002.
25. Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery. 1988;104:947-53.
26. Simon R, Mirlacher M, Sauter G. Tissue microarrays in cancer diagnosis. Expert Rev Mol Diagn. 2003;3:421-30, doi: 10.1586/14737159.3.4.421.
27. Norton AJ, Jordan S, Yeomans P. Brief, high-temperature heat denaturation (pressure cooking): a simple and effective method of antigen retrieval for routinely processed tissues. J Pathol. 1994;173:371-9, doi: 10.1002/path.1711730413.
28. Guesdon JL, Ternynck T, Avrameas S. The use of avidin-biotin interaction in immunoenzimatic techniques. J Histochem Cytochem. 1979;27:1131-9.
29. Kraan MC, Haringman JJ, Ahern MJ, Breedveld FC, Smith MD, Tak PP. Quantification of the cell infiltrate in synovial tissue by digital image analysis. Rheumatology. 2000;39:43-9, doi: 10.1093/rheumatology/39.1.43.
30. Wicht H, Maronde E, Olcese J, Korf H-W. A semiquantitative imageanalytical method for the recovering of dose-response curves in immunocytochemical preparations. J Histochem Cytochem. 1999;47: 411-9.
31. Wang Z, Wang F, Wang W-Q, Gao Q, Wei W-L, Yang Y, et al. Correlation of N-myc downstream-related gene 1 overexpression with progressive growth of colorectal neoplasm. World J Gastroenterol. 2004;10:550-4.
32. Reis EM, Ojopi EP, Alberto FL, Rahal P, Tsukumo F, Mancini UM, et al. Large-scale transcriptome analyses reveal new genetic marker candidates of head, neck and thyroid cancer. Cancer Res. 2005;65:1693-9, doi: 10.1158/0008-5472.CAN-04-3506.
33. Bandyopadhyay S, Pai SK, Hirota S, Hosobe S, Takano Y, Saito K, et al. Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression. Oncogene. 2004;23:5675-81, doi: 10.1038/sj.onc. 1207734.
34. Ando T, Ishiguro H, Kimura M, Mitsui A, Kurehara H, Sugito N, et al. Decreased expression of NDRG1 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma. Dis Esophagus. 2006;19:454-8, doi: 10.1111/j.1442-2050.2006. 00618.x.
35. Maruyama Y, Ono M, Kawahara A, Yokoyama T, Basaki Y, Kage M, et al. Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis. Cancer Res. 2006;66:6233-42, doi: 10.1158/0008-5472.CAN-06-0183.